Literature DB >> 18021849

Intractable wounds caused by calcific uremic arteriolopathy treated with bisphosphonates.

Takaaki Hanafusa1, Yuji Yamaguchi, Mamori Tani, Noriko Umegaki, Yukari Nishimura, Ichiro Katayama.   

Abstract

BACKGROUND: Calcific uremic arteriolopathy (calciphylaxis) is a calcification syndrome that predominantly affects relatively small vessels and is a life-threatening entity usually seen in patients with end-stage renal disease. Intractable skin necrosis sometimes causes lethal sepsis because it progresses rapidly as a result of mechanical stress.
OBJECTIVE: We sought to investigate the efficacy of etidronate disodium (bisphosphonates) in treating intractable ulcers occurred in a patient on hemodialysis accompanied with calcific uremic arteriolopathy. METHODS AND
RESULTS: A 53-year-old patient receiving hemodialysis with chronic renal failure accompanied with calciphylaxis had bilateral leg ulcers caused by minor trauma. The aggressive debridement worsened his skin condition as is usually seen in pyoderma gangrenosum. It eventually healed by lowering calcium-phosphorus levels with the administration of bisphosphonates and with the continuous use of sevelamer hydrochloride. LIMITATIONS: This study reporting a single case limits the interpretation of results.
CONCLUSION: Bisphosphonates may be effective in treating calciphylaxis and arteriosclerosis obliterans by reducing the formation of ectopic calcification around blood vessels.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18021849     DOI: 10.1016/j.jaad.2007.06.029

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  11 in total

1.  Calciphylaxis: a review.

Authors:  Avani Bhambri; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2008-07

Review 2.  Unusual causes of cutaneous ulceration.

Authors:  Jaymie Panuncialman; Vincent Falanga
Journal:  Surg Clin North Am       Date:  2010-12       Impact factor: 2.741

3.  Non-uraemic calciphylaxis successfully treated with pamidronate infusion.

Authors:  David H Truong; Marcus M Riedhammer; Kathya Zinszer
Journal:  Int Wound J       Date:  2018-11-04       Impact factor: 3.315

4.  Painful skin ulcers in a hemodialysis patient.

Authors:  Stuart M Sprague
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 8.237

Review 5.  [Cutaneous calciphylaxis].

Authors:  U Wollina
Journal:  Hautarzt       Date:  2010-12       Impact factor: 0.751

Review 6.  Skin problems in chronic kidney disease.

Authors:  Dirk R J Kuypers
Journal:  Nat Clin Pract Nephrol       Date:  2009-02-03

Review 7.  Cutaneous manifestations of ESRD.

Authors:  Timur A Galperin; Antonia J Cronin; Kieron S Leslie
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-10       Impact factor: 8.237

8.  Calciphylaxis in a patient affected by rheumatoid arthritis, chronic renal failure, and hyperparathyroidism: a case report.

Authors:  Alfredomaria Lurati; Antonella Laria; Donatella Paolotti; Magda Scarpellini
Journal:  Int Med Case Rep J       Date:  2015-05-27

9.  Update on cutaneous calciphylaxis.

Authors:  Uwe Wollina
Journal:  Indian J Dermatol       Date:  2013-03       Impact factor: 1.494

10.  Successful Management of Calciphylaxis in a Kidney Transplant Patient: Case Report.

Authors:  Thomas Welte; Frederic Arnold; Kristin Technau-Hafsi; Elke Neumann-Haefelin; Rika Wobser; Stefan Zschiedrich; Gerd Walz; Albrecht Kramer-Zucker
Journal:  Transplant Direct       Date:  2016-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.